Global Telemedicine Market

2.1    Key Questions Answered in the Report

3.1    Primary Data Sources
3.2    Secondary Data Sources
3.3    Market Estimation Model
3.4    Companies Profiled
3.5    Assumptions and Limitations

4.1    Evolution of Telemedicine
4.2    Need for Telemedicine: A View of Changing Medical Practices
4.3    Telemedicine Changing Medical Practices
4.4    Level of Telemedicine Adoption from a Pre-and Post-COVID-19 Perspective
         4.4.1    Pre-COVID Scenario
         4.4.2    During COVID-19 Scenario
         4.4.3    Post-COVID-19 Scenario
4.5    Competitive Landscape: Existing and New Entrant Competition Analysis
4.6    Funding Scenario
4.7    Reimbursement and Regulatory Scenario

5.1    Business Model and Revenue Channel Analysis (for New Entrants and Existing Players)
5.2    Cost Analysis (in Terms of Infrastructure such as (Hardware/Software/ Services)
         5.2.1    Hardware
         5.2.2    Software
         5.2.3    Teleconsultation Services
5.3    Consumer Spending Analysis
5.4    Readiness of Geographies (in Terms of Digital Infrastructure)

6.1    North America
         6.1.1    U.S.
         6.1.2    Canada
6.2    Europe
         6.2.1    Germany
         6.2.2    France
         6.2.3    Italy
         6.2.4    Spain
         6.2.5    U.K.
6.3    Asia-Pacific
         6.3.1    India
         6.3.2    China
         6.3.3    South Korea
         6.3.4    Japan

7.1    Market Drivers
         7.1.1    Increase in Patient Demand for Virtually Delivered Care
         7.1.2    Increased Reimbursement for Remote Care Services
         7.1.3    Urgent Need to Reduce the Cost of Care
         7.1.4    Increasing Regulatory Approval
7.2    Market Restraints
         7.2.1    Reluctance by Physicians
         7.2.2    Lack of ICT (Information and Communications Technology) Infrastructure in Rural Areas
         7.2.3    Data Privacy
7.3    Market Opportunities
         7.3.1    Accelerated Growth in the Post-COVID-19 World
         7.3.2    Increase in Funding for the Telehealth Start-Up Ecosystem
         7.3.3    Remote Monitoring

8.1    Recent Key Developments
         8.1.1    Product Launches
         8.1.2    Collaborations and Partnerships
         8.1.3    Mergers and Acquisitions
         8.1.4    Funding
         8.1.5    Joint Ventures
8.2    Market Share Analysis

9.1    Hardware
9.2    Software
9.3    Services

10.1    Real-Time Video
10.2    Remote Patient Monitoring (RPM)
10.3    Store and Forward
10.4    Others

11.1    Teleradiology
11.2    Telecardiology
11.3    Telepathology
11.4    Tele-ICU
11.5    Telepsychiatry
11.6    Teledermatology
11.7    Others
           11.7.1    Telestroke
           11.7.2    Tele-endocrinology
           11.7.3    Telegynecology
           11.7.4    Teleophthalmology
           11.7.5    Telenephrology

12.1    Cloud-Based
12.2    On-Premise

13.1    Tele-Hospitals
13.2    Tele-Home

14.1    North America
           14.1.1    U.S.
           14.1.2    Canada
14.2    Europe
           14.2.1    U.K.
           14.2.2    Spain
           14.2.3    Italy
           14.2.4    Germany
           14.2.5    France
           14.2.6    Netherlands
           14.2.7    Poland
           14.2.8    Sweden
           14.2.9    Denmark
           14.2.10    Rest-of-Europe
14.3    Asia-Pacific
           14.3.1    India
           14.3.2    South Korea
           14.3.3    Japan
           14.3.4    Australia
           14.3.5    China
           14.3.6    Rest-of-Asia-Pacific
14.4    Rest-of-the-World
           14.4.1    Brazil
           14.4.2    Mexico
           14.4.3    Kingdom of Saudi Arabia
           14.4.4    United Arab Emirates
           14.4.5    Israel
           14.4.6    South Africa
           14.4.7    Russia
           14.4.8    Rest-of-RoW

15.1    Allscripts Healthcare Solutions, Inc.
           15.1.1    Company Overview
           15.1.2    Role of Allscripts Healthcare Solutions, Inc. in the Global Telemedicine Market
           15.1.3    Product Offerings
           15.1.4    Recent Developments
           15.1.5    Financials
           15.1.6    SWOT Analysis
15.2    AMD Global Telemedicine, Inc.
           15.2.1    Company Overview
           15.2.2    Role of AMD Global Telemedicine, Inc. in the Global Telemedicine Market
           15.2.3    Product Offerings
           15.2.4    Recent Developments
           15.2.5    SWOT Analysis
15.3    American Well
           15.3.1    Company Overview
           15.3.2    Role of American Well in the Global Telemedicine Market
           15.3.3    Product Offerings
           15.3.4    Recent Developments
           15.3.5    SWOT Analysis
15.4    Cisco Systems, Inc.
           15.4.1    Company Overview
           15.4.2    Role of Cisco Systems, Inc. in the Global Telemedicine Market
           15.4.3    Product Offerings
           15.4.4    Recent Developments
           15.4.5    Financials
           15.4.6    SWOT Analysis
15.5    Crossover Health, Inc.
           15.5.1    Company Overview
           15.5.2    Role of Crossover Health, Inc. in the Global Telemedicine Market
           15.5.3    Product Offerings
           15.5.4    Recent Developments
           15.5.5    SWOT Analysis
15.6    Doctor On Demand
           15.6.1    Company Overview
           15.6.2    Role of Doctor On Demand in the Global Telemedicine Market
           15.6.3    Product Offerings
           15.6.4    Recent Developments
           15.6.5    SWOT Analysis
15.7    General Electric Company (GE)
           15.7.1    Company Overview
           15.7.2    Role of General Electric in the Global Telemedicine Market
           15.7.3    Product Offerings
           15.7.4    Recent Developments
           15.7.5    Financials
           15.7.6    SWOT Analysis
15.8    iCliniq
           15.8.1    Company Overview
           15.8.2    Role of iCliniq in the Global Telemedicine Market
           15.8.3    Product Offerings
           15.8.4    SWOT Analysis
15.9    Intel Corporation
           15.9.1    Company Overview
           15.9.2    Role of Intel Corporation in the Global Telemedicine Market
           15.9.3    Product Offerings
           15.9.4    Recent Developments
           15.9.5    Financials
           15.9.6    SWOT Analysis
15.10    International Business Machines Corporation (IBM)
             15.10.1    Company Overview
             15.10.2    Role of IBM in the Global Telemedicine Market
             15.10.3    Product Offerings
             15.10.4    Recent Developments
             15.10.5    Financials
             15.10.6    SWOT Analysis
15.11    Koninklijke Philips N.V.
             15.11.1    Company Overview
             15.11.2    Role of Koninklijke Philips N.V. in the Global Telemedicine Market
             15.11.3    Product Offerings
             15.11.4    Recent Developments
             15.11.5    Financials
             15.11.6    SWOT Analysis
15.12    MDLIVE, Inc.
             15.12.1    Company Overview
             15.12.2    Role of MDLIVE, Inc. in the Global Telemedicine Market
             15.12.3    Product Offerings
             15.12.4    Recent Developments
             15.12.5    SWOT Analysis
15.13    Poly
             15.13.1    Company Overview
             15.13.2    Role of Poly in the Global Telemedicine Market
             15.13.3    Product Offerings
             15.13.4    Recent Developments
             15.13.5    Financials
             15.13.6    SWOT Analysis
15.14    Teladoc Health Inc.
             15.14.1    Company Overview
             15.14.2    Role of Teladoc Health, Inc. in the Global Telemedicine Market
             15.14.3    Product Offerings
             15.14.4    Recent Developments
             15.14.5    Financials
             15.14.6    SWOT Analysis
15.15    VirTrial Inc.
             15.15.1    Company Overview
             15.15.2    Role of VirTrial Inc. in the Global Telemedicine Market
             15.15.3    Product Offerings
             15.15.4    Recent Developments
             15.15.5    SWOT Analysis

Table 4.1:    Timeline for Telemedicine Development
Table 4.2:    Change in Adoption of Telemedicine in Different Medical Specialties (Pre-COVID Scenario)
Table 4.3:    Change in Adoption of Telemedicine in Different Medical Specialties (During COVID-19)
Table 4.4:    Snapshot of Key Participants in the Telemedicine Market
Table 4.5:    U.S. Hospitals with the Highest Funding from FCC's COVID-19 Telehealth Program
Table 4.6:    Recent Funding Rounds Pertaining to the Telemedicine Market
Table 5.1:    A Comparison of Nine Successful Business Models from Diverse Geographic Regions and Revenue Streams
Table 5.2:    Hardware Cost Analysis: Global Telemedicine Market
Table 5.3:    Software Cost Analysis: Global Telemedicine Market
Table 5.4:    Teleconsultation Cost Analysis: Global Telemedicine Market
Table 5.5:    Global Infrastructure for Telemedicine
Table 6.1:    Telemedicine Regulations Followed by States in the U.S.
Table 6.2:    Telemedicine Regulations Followed by Province/Territory in Canada
Table 9.1:    Major Hardware Components Used in Telemedicine Programs
Table 9.2:    Leading Commercially Available Telemedicine Software and their Providers
Table 9.3:    Leading Telemedicine Service Providers in the Market
Table 12.1:    Telemedicine Software Providers offering Cloud solutions/ Cloud and On-Premise Solutions to Healthcare Providers

Figure 1:    Increase in Number of Telehealth Users in the U.S. (2013 and 2018)
Figure 2:    Use of Telehealth in the U.S. Hospitals (2010-2017)
Figure 3:    Global Challenges Inhibiting the Market Growth
Figure 4:    Key Opportunities in the Global Telemedicine Market
Figure 5:    Global Telemedicine Market, $Billion, 2019-2030
Figure 6:    Global Telemedicine Market (by Component Type), $Billion, 2019 and 2030
Figure 7:    Global Telemedicine Market (by Hardware Type), $Billion, 2019, 2025, and 2030
Figure 8:    Global Telemedicine Market (by Type/Service Delivery Model), $Billion, 2019, 2025, and 2030
Figure 9:    Global Telemedicine Market (by Medical Specialty), $Billion, 2019 and 2030
Figure 10:    Global Telemedicine Market (Mode of Delivery), $Billion, 2019-2030
Figure 11:    Global Telemedicine Market (by Type), $Billion, 2019-2030
Figure 12:    Global Telemedicine Market (by Region), $Billion, 2019 and 2030
Figure 2.1:    Global Telemedicine Market Segmentation
Figure 3.1:    Global Telemedicine Market Methodology
Figure 3.2:    Primary Research Methodology
Figure 3.3:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4:    Top-Down Approach (Segment-Wise Analysis)
Figure 4.1:    The Decline in Number of Visits to Ambulatory Practices (Percentage)
Figure 4.2:    A Comparison of Decline in Number of In-Person Visits and All Types of Visits (Telemedicine and In-Person Visits)
Figure 4.3:    Number of Telehealth Visits in a Given Week as a Percent of Baseline Total Visits
Figure 4.4:    Number of Telehealth Visits in a Given Week, by Medical Specialty
Figure 4.5:    Niche Players in the Global Telemedicine Services Market
Figure 4.6:    Global Overall Competitive Ecosystem (Including Hardware + Software)
Figure 8.1:    Share of Key Developments and Strategies (N = 268)
Figure 8.2:    Market Share Analysis for RPM Device Manufacturers in the Telemedicine Market
Figure 8.3:    Market Share Analysis for Software Providers in the Telemedicine Market
Figure 8.4:    Market Share Analysis for Service Providers in the Telemedicine Market
Figure 9.1:    Illustration of Global Telemedicine Market Components
Figure 9.2:    Global Telemedicine Market Share (by Component Type) in 2019
Figure 9.3:    Global Telemedicine Hardware Market, $Billion, 2019-2030
Figure 9.4:    Global Telemedicine Software Market, $Billion, 2019-2030
Figure 9.5:    Global Telemedicine Services Market, $Billion, 2019-2030
Figure 10.1:    Global Telemedicine Market (by Technology)
Figure 10.2:    Global Real-Time Telemedicine Market, $Billion, 2019-2030
Figure 10.3:    Global Remote Monitoring Telemedicine Market, $Billion, 2019-2030
Figure 10.4:    Global Store and Forward Telemedicine Market, $Billion, 2019-2030
Figure 10.5:    Others Telemedicine Type Market, $Billion, 2019-2030
Figure 11.1:    Global Teleradiology Market, $Billion, 2019-2030
Figure 11.2:    Impact of Market Drivers and Market Restraints
Figure 11.3:    Global Telecardiology Market, $Billion, 2019-2030
Figure 11.4:    Global Telepathology Market, $Billion, 2019-2030
Figure 11.5:    Global TeleICU Market, $Billion, 2019-2030
Figure 11.6:    Global Telepsychiatry Market, $Billion, 2019-2030
Figure 11.7:    Global Teledermatology Market, $Billion, 2019-2030
Figure 11.8:    Other Medical Specialty Market, $Billion, 2019-2030
Figure 12.1:    Global Cloud Based Telemedicine Solutions, $Billion, 2019-2030
Figure 12.2:    Global On-Premise Telemedicine Solutions, $Billion, 2019-2030
Figure 13.1:    Global Tele-Hospitals/Teleclinics Market, $Billion, 2019-2030
Figure 13.2:    Global Telehome Market, $Billion, 2019-2030
Figure 14.1:    North America Telemedicine Market, $Billion, 2019-2030
Figure 14.2:    U.S. Telemedicine Market, $Billion, 2019-2030
Figure 14.3:    Canada Telemedicine Market, $Billion, 2019-2030
Figure 14.4:    Europe Telemedicine Market, $Billion, 2019-2030
Figure 14.5:    U.K. Telemedicine Market, $Billion, 2019-2030
Figure 14.6:    Spain Telemedicine Market, $Billion, 2019-2030
Figure 14.7:    Italy Telemedicine Market, $Billion, 2019-2030
Figure 14.8:    Germany Telemedicine Market, $Billion, 2019-2030
Figure 14.9:    France Telemedicine Market, $Billion, 2019-2030
Figure 14.10:    Netherlands Telemedicine Market, $Billion, 2019-2030
Figure 14.11:    Poland Telemedicine Market, $Billion, 2019-2030
Figure 14.12:    Sweden Telemedicine Market, $Billion, 2019-2030
Figure 14.13:    Denmark Telemedicine Market, $Billion, 2019-2030
Figure 14.14:    Rest-of-Europe Telemedicine Market, $Billion, 2019-2030
Figure 14.15:    Asia-Pacific Telemedicine Market, $Billion, 2019-2030
Figure 14.16:    India Telemedicine Market, $Billion, 2019-2030
Figure 14.17:    Japan Telemedicine Market, $Billion, 2019-2030
Figure 14.18:    Australia Telemedicine Market, $Billion, 2019-2030
Figure 14.19:    China Telemedicine Market, $Billion, 2019-2030
Figure 14.20:    Rest-of-Asia-Pacific Telemedicine Market, $Billion, 2019-2030
Figure 14.21:    Rest-of-the-World Telemedicine Market, $Billion, 2019-2030
Figure 14.22:    Brazil Telemedicine Market, $Billion, 2019-2030
Figure 14.23:    Mexico Telemedicine Market, $Billion, 2019-2030
Figure 14.24:    Saudi Arabia Telemedicine Market, $Billion, 2019-2030
Figure 14.25:    U.A.E Telemedicine Market, $Billion, 2019-2030
Figure 14.26:    Israel Telemedicine Market, $Billion, 2019-2030
Figure 14.27:    South Africa Telemedicine Market, $Billion, 2019-2030
Figure 14.28:    Rest-of-RoW Telemedicine Market, $Billion, 2019-2030
Figure 15.1:    Allscripts Healthcare Solutions, Inc.: Telemedicine Offerings
Figure 15.2:    Allscripts Healthcare Solutions, Inc.: Overall Financials, 2017-2019
Figure 15.3:    Allscripts Healthcare Solutions, Inc.: Revenue (by Segment), 2017-2019
Figure 15.4:    Allscripts Healthcare Solutions, Inc.: Revenue (by Region), 2017-2019
Figure 15.5:    Allscripts Healthcare Solutions, Inc.: SWOT Analysis
Figure 15.6:    AMD Global Telemedicine, Inc.: SWOT Analysis
Figure 15.7:    American Well: SWOT Analysis
Figure 15.8:    Cisco Systems, Inc.: Overall Financials, 2017-2019
Figure 15.9:    Cisco Systems, Inc.: Revenue (by Segment), 2017-2019
Figure 15.10:    Cisco Systems, Inc.: Revenue (by Region), 2017-2019
Figure 15.11:    Cisco Systems, Inc.: SWOT Analysis
Figure 15.12:    Crossover Health, Inc.: SWOT Analysis
Figure 15.13:    Doctor On Demand: SWOT Analysis
Figure 15.14:    GE: Overall Financials, 2017-2019
Figure 15.15:    GE.: Revenue (by Segment), 2017-2019
Figure 15.16:    GE.: Revenue (by Sub-Segment), 2017-2019
Figure 15.17:    GE.: Revenue (by Region), 2017-2019
Figure 15.18:    General Electric Company: SWOT Analysis
Figure 15.19:    iCliniq: SWOT Analysis
Figure 15.20:    Intel Corporation: Telemedicine Offerings
Figure 15.21:    Intel Corporation: Overall Financials, 2017-2019
Figure 15.22:    Intel Corporation: Revenue (by Segment), 2017-2019
Figure 15.23:    Intel Corporation: Revenue (by Region), 2017-2019
Figure 15.24:    Intel Corporation: SWOT Analysis
Figure 15.25:    IBM: Overall Financials, 2017-2019
Figure 15.26:    IBM: Revenue (by Segment), 2017-2019
Figure 15.27:    IBM: Revenue (by Region), 2017-2019
Figure 15.28:    International Business Machines (IBM): SWOT Analysis
Figure 15.29:    Koninklijke Philips N.V.: Overall Financials, 2016-2019
Figure 15.30:    Koninklijke Philips N.V.: Revenue (by Segment), 2016-2019
Figure 15.31:    Koninklijke Philips N.V.: Revenue (by Region), 2016-2019
Figure 15.32:    Koninklijke Philips N.V.: SWOT Analysis
Figure 15.33:    MDLIVE, Inc.: SWOT Analysis
Figure 15.34:    Poly: Overall Financials, 2017-2019
Figure 15.35:    Poly: Revenue (by Segment), 2017-2019
Figure 15.36:    Poly: Revenue (by Region), 2017-2019
Figure 15.37:    Poly: SWOT Analysis
Figure 15.38:    Teladoc Health: Overall Financials, 2016-2019
Figure 15.39:    Teladoc Health, Inc.: SWOT Analysis
Figure 15.40:    VirTrial Inc.: SWOT Analysis